Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report)'s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $57.33 and traded as low as $57.05. Utah Medical Products shares last traded at $57.59, with a volume of 15,951 shares.
Utah Medical Products Trading Down 1.4%
The company's 50 day moving average price is $55.30 and its two-hundred day moving average price is $57.31. The stock has a market cap of $183.40 million, a P/E ratio of 14.93 and a beta of 0.28.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 EPS for the quarter. Utah Medical Products had a net margin of 33.00% and a return on equity of 10.74%. The company had revenue of $9.71 million for the quarter.
Utah Medical Products Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 3rd. Stockholders of record on Monday, June 16th were given a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 2.16%. The ex-dividend date of this dividend was Monday, June 16th. Utah Medical Products's payout ratio is currently 32.28%.
Institutional Investors Weigh In On Utah Medical Products
Several institutional investors and hedge funds have recently modified their holdings of the stock. Jane Street Group LLC bought a new stake in shares of Utah Medical Products during the first quarter valued at approximately $317,000. Huber Capital Management LLC raised its position in shares of Utah Medical Products by 38.9% during the first quarter. Huber Capital Management LLC now owns 39,819 shares of the medical instruments supplier's stock valued at $2,231,000 after buying an additional 11,149 shares during the last quarter. Jump Financial LLC bought a new stake in shares of Utah Medical Products during the first quarter valued at approximately $370,000. Hotchkis & Wiley Capital Management LLC raised its position in shares of Utah Medical Products by 35.2% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier's stock valued at $5,696,000 after buying an additional 26,460 shares during the last quarter. Finally, American Century Companies Inc. increased its position in Utah Medical Products by 6.8% in the first quarter. American Century Companies Inc. now owns 8,690 shares of the medical instruments supplier's stock worth $487,000 after purchasing an additional 555 shares during the last quarter. Institutional investors own 69.60% of the company's stock.
Utah Medical Products Company Profile
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Further Reading
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
